Healthcare


 How GSK's New Five-in-One Vaccine is Shaping the Meningitis Landscape

How GSK's New Five-in-One Vaccine is Shaping the Meningitis Landscape

February 17, 2025 11:31 PM AEDT| By Team Kalkine Media

How GSK's New Five-in-One Vaccine is Shaping the Meningitis Landscape

 Is hVIVO PLC (LON:HVO) Gearing Up for Significant Growth with New Contract Wins

Is hVIVO PLC (LON:HVO) Gearing Up for Significant Growth with New Contract Wins

February 17, 2025 11:30 PM AEDT| By Team Kalkine Media

Is hVIVO PLC (LON:HVO) Gearing Up for Significant Growth with New Contract Wins

 Transforming Cancer Immunotherapy Scancell Holdings PLC's Breakthrough in the SCOPE Trial

Transforming Cancer Immunotherapy Scancell Holdings PLC's Breakthrough in the SCOPE Trial

February 17, 2025 08:12 PM AEDT| By Team Kalkine Media

Transforming Cancer Immunotherapy Scancell Holdings PLC's Breakthrough in the SCOPE Trial

 Creo Medical Group PLC Pioneering Innovation in Minimally Invasive Surgery

Creo Medical Group PLC Pioneering Innovation in Minimally Invasive Surgery

February 17, 2025 08:11 PM AEDT| By Team Kalkine Media

Creo Medical Group PLC Pioneering Innovation in Minimally Invasive Surgery

 hVIVO PLC Pioneering Vaccine Development with Human Challenge Trials

hVIVO PLC Pioneering Vaccine Development with Human Challenge Trials

February 17, 2025 07:31 PM AEDT| By Team Kalkine Media

hVIVO PLC Pioneering Vaccine Development with Human Challenge Trials

 Grass MATA MPL Revolutionizing Allergy Immunotherapy

Grass MATA MPL Revolutionizing Allergy Immunotherapy

February 17, 2025 07:31 PM AEDT| By Team Kalkine Media

Grass MATA MPL Revolutionizing Allergy Immunotherapy

 Creo Medical Achieves Growth in Core Technology and Strategic Expansion

Creo Medical Achieves Growth in Core Technology and Strategic Expansion

February 17, 2025 06:29 PM AEDT| By Team Kalkine Media

Highlights,Creo Core Technology Revenue Soars:,74% increase to £4.0m, driven by growing adoption of Speedboat UltraSlim and CROMA platform.,Cost Reductions & Strategic Sale:,£5.0m in cost savings achieved in H2 2024, with further benefits expected in...

 Roquefort Therapeutics PLC Transforming Early-Stage Biotech into Breakthrough Therapies

Roquefort Therapeutics PLC Transforming Early-Stage Biotech into Breakthrough Therapies

February 15, 2025 04:30 AM AEDT| By Team Kalkine Media

Roquefort Therapeutics PLC Transforming Early-Stage Biotech into Breakthrough Therapies

 Totally PLC (AIM:TLY) Shares Plunge After Contract Loss

Totally PLC (AIM:TLY) Shares Plunge After Contract Loss

February 14, 2025 09:30 PM AEDT| By Team Kalkine Media

Totally PLC (AIM:TLY) Shares Plunge After Contract Loss

 GENinCode (LSE:GENI) Accelerates Global Expansion in Biotechnology

GENinCode (LSE:GENI) Accelerates Global Expansion in Biotechnology

February 14, 2025 08:30 PM AEDT| By Team Kalkine Media

GENinCode (LSE:GENI) Accelerates Global Expansion in Biotechnology

 Transforming Pharmaceuticals AstraZeneca’s Evolving Strategy and Pipeline Diversification

Transforming Pharmaceuticals AstraZeneca’s Evolving Strategy and Pipeline Diversification

February 14, 2025 02:31 AM AEDT| By Team Kalkine Media

Transforming Pharmaceuticals AstraZeneca’s Evolving Strategy and Pipeline Diversification

 ImmuPharma PLC (AIM:IMM) Transforms Autoimmune Research with Strategic Funding and Innovation

ImmuPharma PLC (AIM:IMM) Transforms Autoimmune Research with Strategic Funding and Innovation

February 13, 2025 07:31 PM AEDT| By Team Kalkine Media

ImmuPharma PLC (AIM:IMM) Transforms Autoimmune Research with Strategic Funding and Innovation

 IXICO Revolutionizes Neuroimaging in Clinical Trials for Neurological Disorders

IXICO Revolutionizes Neuroimaging in Clinical Trials for Neurological Disorders

February 13, 2025 07:31 PM AEDT| By Team Kalkine Media

IXICO Revolutionizes Neuroimaging in Clinical Trials for Neurological Disorders

 AstraZeneca's Strategic Momentum in Pharma Innovation

AstraZeneca's Strategic Momentum in Pharma Innovation

February 13, 2025 03:32 PM AEDT| By Team Kalkine Media

AstraZeneca's Strategic Momentum in Pharma Innovation

 GSK PLC's Specialty Medicines Powering Global Healthcare Innovation

GSK PLC's Specialty Medicines Powering Global Healthcare Innovation

February 13, 2025 03:31 PM AEDT| By Team Kalkine Media

GSK PLC's Specialty Medicines Powering Global Healthcare Innovation

 How Is Beximco Pharmaceuticals Performing In The Market?

How Is Beximco Pharmaceuticals Performing In The Market?

February 13, 2025 10:53 AM AEDT| By Team Kalkine Media

Highlights:,Beximco Pharmaceuticals' stock moved above its fifty-day average,,indicating,recent market activity.,The company has a long-standing presence in the pharmaceutical sector, manufacturing and exporting medicines globally.,Market activity re...

 Is GSK Facing Setbacks Amidst Recent Earnings Performance?

Is GSK Facing Setbacks Amidst Recent Earnings Performance?

February 12, 2025 08:15 PM AEDT| By Team Kalkine Media

Highlights:,GSK's stock opened lower with fluctuating price trends.,The company reports a notable net margin and return on equity.,A 52-week low and high reveal a wider price range.,GSK (LSE:GSK) operates in the healthcare sector, focusing on pharmac...

 EKF Diagnostics Faces Decline As Stock Drops Below Key Average

EKF Diagnostics Faces Decline As Stock Drops Below Key Average

February 12, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,EKF Diagnostics shares recently dropped below their 200-day moving average.,The company focuses on diagnostics, specializing in Hematology and Diabetes.,EKF operates five manufacturing sites in the US and Germany, serving over 120 countri...

 Could Institutional Investors Influence GSK plc (LON:GSK) After a Notable Shift?

Could Institutional Investors Influence GSK plc (LON:GSK) After a Notable Shift?

February 10, 2025 10:15 PM AEDT| By Team Kalkine Media

Highlights,Institutional ownership of GSK plc,(LON:GSK),stands at 86%, making it highly sensitive to their trading decisions.,A small group of 23 institutional investors collectively control over half of the company's shares.,Recent valuation changes...

 Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts

Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts

February 10, 2025 08:32 PM AEDT| By Team Kalkine Media

Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s

Recent Articles






Investing Tips

Previous Next